Be Part of the Next Wave of Breakthroughs for Congenital Heart Disease With Cord Blood Treatment
In a matter of just a few decades, the advancements made for congenital heart disease (CHD) care have been astounding. Just thirty years ago, doctors were figuring out how a baby with a congenital heart defect could survive to their first birthday. Today, we are focusing on how to ensure these children thrive in every domain as they enter into adulthood.
But the work does not stop there. Even with therapeutic and patient care advancements, many CHD patients that receive prosthetic devices or material to repair cardiac structures including valves, patches and vessels will require life-long therapy to limit clotting and rejection. In addition, many recipients will need additional surgeries later in life as they outgrow their implant. The next wave of CHD research explores how we can further advance these therapeutic approaches and overcome current limitations by using a patient’s own cells for more precise and personalized treatments.
The development of the Cord Blood Program at the Herma Heart Institute reflects our continued investment in this next wave of research — known as Precision Medicine. Now, our Cord Blood Program is looking to partner with families to store valuable cord blood and tissue after the birth of their baby pre-diagnosed with CHD in utero. Their umbilical blood or tissue holds the potential to unlock new personalized treatments and therapies for CHD patients and their families in the years to come.
The Herma Heart Institute Difference
The first cord blood bankings facility was established in the late 1980s. Today, there are a handful of cord blood banks throughout the United States that store cord blood to use in future clinical treatments. Families who use these cord blood storage facilities usually pay an upfront cost as well as annual storage fees.
However, the Cord Blood Program at the Herma Heart Institute is able to provide this service at no charge to families. By participating in our program, the cord blood (and tissue) will be used by the Herma Heart Institute’s research team to develop new therapies and treatments for the future, and will be available to you to retrieve at any time.
How To Participate in the Cord Blood Program
Participation in this program is not limited to patients of the Herma Heart Institute, and we encourage all CHD families to participate in this initiative. Interested participants can learn more about the program by talking to their fetal care team, physician, or by filling out the form below. We will respond within 2 business days.




